Literature DB >> 8972459

Increased formation of phosphatidylinositol-4-phosphate in human platelets stimulated with lysophosphatidic acid.

I Mani1, D C Gaudette, B J Holub.   

Abstract

Lysophosphatidic acid (LPA, 1-acyl-sn-glycerol 3-phosphate), at a concentration of 1-40 microM, was found to induce the formation of [3H]inositol-labelled phosphatidylinositol-4-phosphate (PIP) without significantly altering the levels of either phosphatidylinositol (PI) or phosphatidylinositol bisphosphate (PIP2) in washed human platelets. Preincubation of platelets with the cyclooxygenase/lipoxygenase inhibitor, BW755C at 100 microM, did not alter the LPA-induced formation of PIP. Activation of platelets with the phorbol ester, phorbol 12-myristate 13-acetate (PMA), elicited a similar response (induction of PIP formation). The specific protein kinase C (PKC) inhibitor, GF109203X (10 microM), completely blocked the effect of PMA but not the LPA-induced generation of PIP. The present results indicate that LPA can induce PIP formation via PI-4-kinase activation, through processes which are independent of the eicosanoid/TxA2 pathway and are not PKC-dependent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972459     DOI: 10.1007/bf02587911

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  A calcium-activated polyphosphoinositide phosphodiesterase in the plasma membrane of human and rabbit erythrocytes.

Authors:  D Allan; R H Michell
Journal:  Biochim Biophys Acta       Date:  1978-04-04

2.  Enhanced phosphatidylinositol kinase activity is associated with early stages of hepatocarcinogenesis and hepatocellular carcinoma.

Authors:  J W Olson
Journal:  Biochem Biophys Res Commun       Date:  1985-11-15       Impact factor: 3.575

3.  Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.

Authors:  J M Gerrard; P Robinson
Journal:  Biochim Biophys Acta       Date:  1984-10-04

4.  Phorbol myristate acetate stimulates formation of phosphatidyl inositol 4-phosphate and phosphatidyl inositol 4,5-bisphosphate in human platelets.

Authors:  S P Halenda; M B Feinstein
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

5.  1-Oleoyl-2-acetyl-glycerol (OAG) stimulates the formation of phosphatidylinositol 4-phosphate in intact human platelets.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

6.  Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.

Authors:  S P Watson; R T McConnell; E G Lapetina
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

7.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

8.  Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.

Authors:  E J van Corven; A van Rijswijk; K Jalink; R L van der Bend; W J van Blitterswijk; W H Moolenaar
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

9.  Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes.

Authors:  J B Smith; C Dangelmaier; G Mauco
Journal:  Biochim Biophys Acta       Date:  1985-07-09

10.  Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of Wortmannin on phosphoinositide 3-kinase and aggregation.

Authors:  J Zhang; S E Rittenhouse
Journal:  Biochem Biophys Res Commun       Date:  1995-06-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.